Literature DB >> 17276499

Abnormalities of homocysteine and B vitamins in the nephrotic syndrome.

Gian Marco Podda1, Federico Lussana, Gabriella Moroni, Elena M Faioni, Rossana Lombardi, Gessica Fontana, Claudio Ponticelli, Claudio Maioli, Marco Cattaneo.   

Abstract

INTRODUCTION: The nephrotic syndrome is associated with heightened risk for arterial and venous thrombosis. Multiple derangements of hemostasis and acquired risk factors such as hyperlipidemia and hypertension contribute to this risk. The prevalence in the nephrotic syndrome of high circulating levels of homocysteine and of low levels of the B vitamins that are involved in its metabolism, which may play a role in thrombosis, is not well defined.
MATERIALS AND METHODS: In 84 patients with nephrotic syndrome and 84 sex- and age-matched controls, hemostasis variables and the circulating levels of total homocysteine (tHcy), vitamin B(6), B(12) and folates were measured.
RESULTS: tHcy levels were higher, vitamin B(6) and vitamin B(12) levels were lower in nephrotic patients than in controls. The association of low vitamin B(6) levels with the nephrotic syndrome was independent of any other alteration associated with the disease. Eighty-two percent of patients with the nephrotic syndrome had vitamin B(6) levels falling in the lowest quartile of the normal distribution. Antithrombin deficiency, factor V Leiden, antiphospholipid antibodies, hypertension, dyslipidemia, were more frequent in patients with the nephrotic syndrome than in controls.
CONCLUSIONS: Patients with the nephrotic syndrome have multiple risk factors for thrombosis. We report that they frequently have low circulating levels of vitamin B(6), which associate with a heightened risk for venous and arterial thrombosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17276499     DOI: 10.1016/j.thromres.2006.12.011

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

1.  Homocysteine metabolism in children with idiopathic nephrotic syndrome.

Authors:  Mohan Kundal; Abhijeet Saha; N K Dubey; Kanika Kapoor; Trayambak Basak; Gaurav Bhardwaj; Vinay Singh Tanwar; Shantanu Sengupta; Vinita Batra; Ashish Dutt Upadhayay; Ajay Bhatt
Journal:  Clin Transl Sci       Date:  2014-01-23       Impact factor: 4.689

2.  Trace elements in children suffering from idiopathic nephrotic syndrome.

Authors:  Sebahat Tulpar; Zubeyde Gunduz; Ugur Sahin; M Hakan Poyrazoglu; Ismail Dursun; Ruhan Dusunsel; Funda Bastug
Journal:  Eurasian J Med       Date:  2014-07-08

3.  Prophylaxis with AT III for thromboembolism in nephrotic syndrome: why should it be done?

Authors:  Marco Zaffanello; Milena Brugnara; Vassilios Fanos; Massimo Franchini
Journal:  Int Urol Nephrol       Date:  2008-08-12       Impact factor: 2.370

4.  Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome.

Authors:  Maria H Kniazewska; Anna K Obuchowicz; Tomasz Wielkoszyński; Joanna Zmudzińska-Kitczak; Katarzyna Urban; Marta Marek; Jolanta Witanowska; Karolina Sieroń-Stołtny
Journal:  Pediatr Nephrol       Date:  2008-10-30       Impact factor: 3.714

5.  Plasma homocysteine and B vitamins levels in Nigerian children with nephrotic syndrome.

Authors:  Bose Etaniamhe Orimadegun; Adebola Emmanuel Orimadegun; Adebowale Dele Ademola; Emmanuel Oluyemi Agbedana
Journal:  Pan Afr Med J       Date:  2014-06-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.